Abstract
Abstract
Background
The coronavirus disease 2019 (COVID-19) pandemic has had a significant impact on the neurodevelopment of children. However, the precise effects of the virus and the social consequences of the pandemic on pediatric neurodevelopment are not yet fully understood. We aimed to compare the neurodevelopment of children between before and during the COVID-19 pandemic, as well as examine the impact of socioeconomic status (SES) and regional differences on the development.
Methods
The study used the Korean Developmental Screening Test to compare the difference in the risk of neurodevelopmental delay between before and during the COVID-19 pandemic. Multivariable logistic regression analysis was conducted to identify the relationship between experiencing the COVID-19 pandemic and the risk of neurodevelopmental delay. Stratified analyses were performed to determine whether the developmental delays caused by the pandemic’s impact varied depending on SES or regional inequality.
Results
This study found an association between the experience of COVID-19 and a higher risk of neurodevelopmental delay in communication (adjusted OR [aOR]: 1.21, 95% confidence interval [CI]: 1.19, 1.22; P-value: < 0.0001) and social interaction (aOR: 1.15, 95% CI: 1.13, 1.17; P-value: < 0.0001) domains among children of 30–36 months’ ages. Notably, the observed association in the Medicaid group of children indicates a higher risk of neurodevelopmental delay compared to those in the non-Medicaid group.
Conclusions
These findings highlight the need to be concerned about the neurodevelopment of children who experienced the COVID-19 pandemic. The study also calls for increased training and support for Medicaid children, parents, teachers, and healthcare practitioners. Additionally, policy programs focused on groups vulnerable to developmental delays are required.
Publisher
Springer Science and Business Media LLC
Reference45 articles.
1. Zanke AA, Thenge RR, Adhao VS. COVID-19: a pandemic declare by world health organization. IP Int J Compr Adv Pharmacol. 2020;5(2):49–57.
2. WHO coronavirus (COVID-19). dashboard. https://covid19.who.int/ (Accessed 4 August 2023).
3. COVID-19 occurence status. https://ncov.kdca.go.kr/en/ (Accessed 4 August 2023).
4. Shin E, Choe YJ, Ryu B, Kim N-Y, Lee HJ, Kim DH, Kim S-S, Kwon D, Yun KW, Park SE. Pediatric deaths Associated with Coronavirus Disease 2019 (COVID-19) in Korea. J Korean Med Sci 2022, 38(3).
5. Yoo S, Managi S. Global mortality benefits of COVID-19 action. Technol Forecast Soc Chang. 2020;160:120231.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献